Eikon Therapeutics, Inc. (EIKN)
7.26
-0.98
(-11.89%)
USD |
NASDAQ |
Oct 23, 16:00
7.24
-0.02
(-0.28%)
After-Hours: 20:00
Eikon Therapeutics EPS Diluted (Quarterly) : -1.633 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.633 |
| March 31, 2026 | -1.532 |
| December 31, 2025 | -1.471 |
| Date | Value |
|---|---|
| June 30, 2025 | -1.943 |
| March 31, 2025 | -1.477 |
| December 31, 2024 | -1.287 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -88.41M |
| Total Expenses (Quarterly) | 88.41M |
| Enterprise Value | 113.76M |
| Earnings Yield | -90.63% |
| Normalized Earnings Yield | -90.63 |